Next-generation sequencing (NGS), massively parallel or deep sequencing is a related term describing DNA sequencing technology that has revolutionized genome research. The development of sequencing-based chromatin analysis technology allows current researchers to experimentally measure the properties of chromatin. NGS is the choice for large-scale genome and transcriptome sequencing. This is because the high-throughput sequencing data generated and output by each instrument is in the gigabyte range, and the cost is compared with the traditional Sanger first-generation sequencing method.
The difference between NGS technology and Sanger method is that they provide large-scale parallel analysis, which can provide ultra-high throughput of multiple samples at a greatly reduced cost. Millions to billions of DNA nucleotides can be sequenced in parallel, which significantly increases yields and minimizes the need for fragment cloning methods used in Sanger Sequencing.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy